1.
Pediatr Infect Dis J
; 31(7): 771-3, 2012 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22481426
RESUMO
The current treatment for dengue hemorrhagic fever largely consists of supportive care. The drug pentoxifylline has been shown to blunt the proinflammatory actions of tumor necrosis factor-α, a key mediator of dengue hemorrhagic fever. We performed a pilot study evaluating pentoxifylline's effect on 55 children with dengue hemorrhagic fever. We believe our findings support the existing literature on its potential use in severe infection.